1-20 of 39
Jian Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aberrant Nuclear Export of circNCOR1 Underlies SMAD7-Mediated Lymph Node Metastasis of Bladder Cancer

Mingjie An, Hanhao Zheng, Jian Huang, Yan Lin, Yuming Luo, Yao Kong, Mingrui Pang, Dingwen Zhang, Jiabin Yang, Jiancheng Chen, Yuanlong Li, Changhao Chen, Tianxin Lin
Journal: Cancer Research
Cancer Res canres.4349.2021.
DOI: https://doi.org/10.1158/0008-5472.CAN-21-4349
Published: 08 April 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract P2-13-10: First-in-human HER2-targeted bispecific antibody KN026 for the treatment of patients with HER2-positive metastatic breast cancer: Results from a phase I study

Jian Zhang, Dongmei Ji, Li Cai, Herui Yao, Min Yan, Xiaojia Wang, Weina Shen, Yiqun Du, Hui Pang, Xiuping Lai, Huiai Zeng, Jian Huang, Yan Sun, Xinxin Peng, Junfang Xu, Jing Yang, Fei Yang, Ting Xu, Xichun Hu
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-13-10.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P2-13-10
Published: 15 February 2022
View article
Journal Articles

Abstract P2-13-31: Pyrotinib in combination with docetaxel as first-line treatment for HER2-positive metastatic breast cancer (PANDORA): A single-arm, multicenter phase 2 trial

Xiaojia Wang, Jian Huang, Yabing Zheng, Xiying Shao, Wenming Cao, Zhanhong Chen, Yanxia Shi, Li Cai, Wenyan Chen, Zhen Guo, Jian Liu, Peng Shen, Yiding Chen, Xian Wang, Huiping Li, Man Li
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-13-31.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P2-13-31
Published: 15 February 2022
View article
Journal Articles

Abstract P5-18-06: Proactive diarrhea management improved tolerability of pyrotinib in combination with trastuzumab and docetaxel in patients with HER2+ early or locally advanced breast cancer: Exploratory analysis from randomized, double-blind, phase 3 PHEDRA study

Benlong Yang, Jiong Wu, Zhenzhen Liu, Hongjian Yang, Jinhai Tang, Kun Wang, Yunjiang Liu, Haibo Wang, Peifen Fu, Shuqun Zhang, Qiang Liu, Zefei Jiang, Shusen Wang, Jian Huang, Chuan Wang, Shu Wang, Yongsheng Wang, Linlin Zhen, Fei Wu, Shulin Liu, Xiang Lin, Jianjun Zou
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-18-06.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P5-18-06
Published: 15 February 2022
View article
Journal Articles

Abstract OT2-27-02: A prospective phase II study on efficacy and safety of anlotinib combined with fulvestrant in patients with HR-positive and HER2-negative, secondary endocrine-resistant, locally advanced or metastatic breast cancer

Xiaojia Wang, Jian Huang
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT2-27-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-OT2-27-02
Published: 15 February 2022
View article
Journal Articles

Abstract P1-17-04: Hormone therapy (HT) brings more survival benefits than capecitabine (CAP) as maintenance therapy following the 1st-line chemotherapy in HR+/HER2-ABC/MBC: Update primary endpoint of OVERSTEP(ZJCHBC001)

Xiao-Jia Wang, Jian Huang, Xi-ying Shao, Li Cai, Yong-mei Yin, Li-li Zhang, Peng Shen, Yan-xia Shi
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-17-04.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-17-04
Published: 15 February 2022
View article
Journal Articles

Abstract GS1-06: A randomized control phase III trial of entinostat, a once weekly, class I selective histone deacetylase inhibitor, in combination with exemestane in patients with hormone receptor positive advanced breast cancer

Binghe Xu, Qingyuan Zhang, Xichun Hu, Qing Li, Tao Sun, Wei Li, Quchang Ouyang, Jingfen Wang, Zhongsheng Tong, Min Yan, Huiping Li, Xiaohua Zeng, Changping Shan, Xian Wang, Xi Yan, Jian Zhang, Yue Zhang, Jiani Wang, Liang Zhang, Ying Lin, Jifeng Feng, Qianjun Chen, Jian Huang, Yongkui Lu, Hongsheng Li, Jinsheng Wu, Jing Cheng, Yanrong Hao, Cuizhi Geng, Min Lu, Yanping Li, Xi Chen, Lihua Song, Xueying Wu, Changlu Hu, Xinhong Wu, Xiaojia Wang, Yueyin Pan, Yuehong Cui, Guohua Yu, Sanyuan Sun
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): GS1-06.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-GS1-06
Published: 15 February 2022
View article
Journal Articles

Abstract PD8-08: Pyrotinib in combination with trastuzumab and docetaxel as neoadjuvant treatment for HER2-positive early or locally advanced breast cancer (PHEDRA): A randomized, double-blind, multicenter, phase 3 study

Jiong Wu, Zhenzhen Liu, Hongjian Yang, Jinhai Tang, Kun Wang, Yunjiang Liu, Haibo Wang, Peifen Fu, Shuqun Zhang, Qiang Liu, Zefei Jiang, Shusen Wang, Jian Huang, Chuan Wang, Shu Wang, Yongsheng Wang, Linlin Zhen, Xiaoyu Zhu, Fei Wu, Tao Zhang, Jianjun Zou
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD8-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD8-08
Published: 15 February 2022
View article
Journal Articles

Abstract P5-18-10: Mecapegfilgrastim for primary prophylaxis of neutropenia in 355 HER2+ breast cancer patients treated with neoadjuvant docetaxel in combination with trastuzumab and/or pyrotinib: Exploratory analysis from randomized, double-blind, phase 3 PHEDRA study

Min He, Benlong Yang, Jiong Wu, Zhenzhen Liu, Hongjian Yang, Jinhai Tang, Kun Wang, Yunjiang Liu, Haibo Wang, Peifen Fu, Shuqun Zhang, Qiang Liu, Zefei Jiang, Shusen Wang, Jian Huang, Chuan Wang, Shu Wang, Yongsheng Wang, Linlin Zhen, Xiaoyu Zhu, Shulin Liu, Ping Yan, Jianjun Zou
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-18-10.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P5-18-10
Published: 15 February 2022
View article
Journal Articles

TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors

Silvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska, Konstantin Golovine, Katherine Sullivan-Reed, Wangisa M.B. Dunuwille, Joseph Nacson, Michael Hulse, Kelsey Keith, Jozef Madzo, Lisa Beatrice Caruso, Zachary Gazze, Zhaorui Lian, Antonella Padella, Kumaraswamy N. Chitrala, Boris A. Bartholdy, Ksenia Matlawska-Wasowska, Daniela Di Marcantonio, Giorgia Simonetti, Georg Greiner, Stephen M. Sykes, Peter Valent, Elisabeth M. Paietta, Martin S. Tallman, Hugo F. Fernandez, Mark R. Litzow, Mark D. Minden, Jian Huang, Giovanni Martinelli, George S. Vassiliou, Italo Tempera, Katarzyna Piwocka, Neil Johnson, Grant A. Challen, Tomasz Skorski
Journal: Cancer Research
Cancer Res (2021) 81 (19): 5089–5101.
DOI: https://doi.org/10.1158/0008-5472.CAN-20-3761
Published: 01 October 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract PS13-25: Management of abemaciclib associated diarrhea in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Analysis of the MONARCH plus study

Zefei Jiang, Xichun Hu, Qingyuan Zhang, Tao Sun, Yongmei Yin, Huiping Li, Min Yan, Zhongsheng Tong, Christina Pimentel Oppermann, Yunpeng Liu, Romulo Costa, Man Li, Xi Chen, Ying Cheng, Quchang Ouyang, Ning Liao, Xiaojia Wang, Xinhong Wu, Jifeng Feng, Roberto Hegg, Govindbabu Kanaka Setty, Amit Agarwal, Jyoti Bajpai, Jing Cheng, Gustavo Girotto, Chanchal Goswami, Wenjing Hu, Jian Huang, MA Coccia Portugal, Jin Yang, Rongsheng Zheng, Fabio Andre Franke, Qiang Liu, Yunjiang Liu, Yongkui Lu, Cristiano Souza, Shiying Yu, Nalini Kilara, Harsha Panchal, Ashish Singh, Shona Nag, Jian Liu, Bernardo Rapoport, Neonyana Keorapetse Rebecca Tabane, Hongxia Wang, Ning Wang, Rubing Han, Wanli Zhang
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS13-25.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS13-25
Published: 15 February 2021
View article
Journal Articles

Abstract PS13-01: Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer

Jian Huang, Xiying Shao, Li Cai, Yanxia Shi, Zhanhong Chen, Ping Huang, Yongmei Yin, Lili Zhang, Peng Shen, Wenming Cao, Weiwu Ye, Yuan Huang, Caijin Lou, Lei Lei, Yabin Zheng, Weibin Zou, Junqing Chen, Xiaojia Wang
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS13-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS13-01
Published: 15 February 2021
View article
Journal Articles

Abstract 3174: Genomic alterations of TGFβ signaling genes as novel biomarkers for immunotherapy in patients with non-small cell lung cancer

Shuben Li, Chengzhi Zhou, Jian Huang, Shiyue Zhang, Jiqiang He, Hui Chen, Shaohua Yuan, Weiwei Shi
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3174.
DOI: https://doi.org/10.1158/1538-7445.AM2020-3174
Published: 15 August 2020
View article
Journal Articles

A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220

Panpan Hou, Chao Wu, Yuchen Wang, Rui Qi, Dheeraj Bhavanasi, Zhixiang Zuo, Cedric Dos Santos, Shuliang Chen, Yu Chen, Hong Zheng, Hong Wang, Alexander Perl, Deyin Guo, Jian Huang
Journal: Cancer Research
Cancer Res (2017) 77 (16): 4402–4413.
DOI: https://doi.org/10.1158/0008-5472.CAN-16-1627
Published: 14 August 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 5042: A CRISPR/Cas9 knockout screen identify novel drug resistance genes in AML

Jian Huang
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 5042.
DOI: https://doi.org/10.1158/1538-7445.AM2016-5042
Published: 15 July 2016
View article
Journal Articles

Abstract P5-09-02: The CYP19 RS4646 polymorphism is related to the prognosis of stage I–II and operable stage III breast cancers

Xiying Shao, Xiaojia Wang, Yangbing Zheng, Ping Huang, Jian Huang
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P5-09-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-P5-09-02
Published: 01 May 2015
View article
Journal Articles

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

Xiaomei Zhang, Sofie Claerhout, Aleix Prat, Lacey E. Dobrolecki, Ivana Petrovic, Qing Lai, Melissa D. Landis, Lisa Wiechmann, Rachel Schiff, Mario Giuliano, Helen Wong, Suzanne W. Fuqua, Alejandro Contreras, Carolina Gutierrez, Jian Huang, Sufeng Mao, Anne C. Pavlick, Amber M. Froehlich, Meng-Fen Wu, Anna Tsimelzon, Susan G. Hilsenbeck, Edward S. Chen, Pavel Zuloaga, Chad A. Shaw, Mothaffar F. Rimawi, Charles M. Perou, Gordon B. Mills, Jenny C. Chang, Michael T. Lewis
Journal: Cancer Research
Series: Author Choice
Cancer Res (2013) 73 (15): 4885–4897.
DOI: https://doi.org/10.1158/0008-5472.CAN-12-4081
Published: 31 July 2013
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 4028: Therapeutic relevance of two novel cancer candidate genes, RASAL2 and NENF, activated by DNA hypomethylation

Barbara Stefanska, Matthew Suderman, Jian Huang, Michael Hallett, Ze-Guang Han, Moshe Szyf
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4028.
DOI: https://doi.org/10.1158/1538-7445.AM2012-4028
Published: 15 April 2012
View article
Journal Articles

Abstract 1210: Tetraspanin CD63 interacts with extranuclear estrogen receptor alpha and regulates non-genomic signaling pathways in breast cancer

Jian Huang, Alexander Craig Mackinnon, Liying Jiang
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1210.
DOI: https://doi.org/10.1158/1538-7445.AM2012-1210
Published: 15 April 2012
View article
Journal Articles

Abstract 2152: p38α MAPK regulates signal transduction between estrogen receptor (ER) and its antagonist by switching ER signaling from the classical to the non-classical pathway

Guan Chen, Huiying Zhi, Songwang Hou, Phillip Wang, Jian Huang, Zainab Basir, Christopher R. Chitambar, Xiaomei Qi
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2152.
DOI: https://doi.org/10.1158/1538-7445.AM2012-2152
Published: 15 April 2012
View article